XML 21 R8.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Restricted stock units
Common stock
Common stock
Restricted shares
Common stock
Restricted stock units
Additional capital in excess of par value
Additional capital in excess of par value
Restricted stock units
Retained earnings
AOCI
 [1]
Beginning balance (in shares) at Dec. 31, 2019     235,214,000            
Balances at beginning of period at Dec. 31, 2019 $ 7,102.1   $ 47.0     $ 654.6   $ 6,443.5 $ (43.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 946.1             946.1  
Other comprehensive income (loss), net of tax (9.2)               (9.2)
Dividends declared (425.1)             (425.1)  
Shares issued upon option exercises (in shares)     1,364,000            
Shares issued upon option exercises 57.2   $ 0.3     56.9      
Restricted shares issued, net of shares withheld for taxes (in shares)       8,000          
Net shares issued upon vesting of restricted stock units (in shares)         43,000        
Net shares issued upon vesting of restricted stock units   $ (3.3)         $ (3.3)    
Stock-based compensation expense 111.6         111.6      
Restricted stock units issued as dividend equivalents           0.1   (0.1)  
Common shares repurchased (in shares)     (9,639,000)            
Common shares repurchased (1,028.7)   $ (1.9)     (165.3)   (861.5)  
Ending balance (in shares) at Jun. 30, 2020     226,990,000            
Balances at end of period at Jun. 30, 2020 6,750.7   $ 45.4     654.6   6,102.9 (52.2)
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2019 1,121.0                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (loss) attributable to redeemable non-controlling interests (51.0)                
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests 6.9                
Net subscriptions into T. Rowe Price investment products 89.9                
Net deconsolidations of T. Rowe Price investment products (62.9)                
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2020 1,090.1                
Beginning balance (in shares) at Mar. 31, 2020     227,985,000            
Balances at beginning of period at Mar. 31, 2020 6,434.0   $ 45.6     654.6   5,782.9 (49.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 603.0             603.0  
Other comprehensive income (loss), net of tax (3.1)               (3.1)
Dividends declared (210.3)             (210.3)  
Shares issued upon option exercises (in shares)     296,000            
Shares issued upon option exercises 15.9   $ 0.1     15.8      
Restricted shares issued, net of shares withheld for taxes (in shares)       8,000          
Net shares issued upon vesting of restricted stock units (in shares)         6,000        
Net shares issued upon vesting of restricted stock units   (0.3)         (0.3)    
Stock-based compensation expense 53.3         53.3      
Restricted stock units issued as dividend equivalents           0.1   (0.1)  
Common shares repurchased (in shares)     (1,305,000)            
Common shares repurchased (141.8)   $ (0.3)     (68.9)   (72.6)  
Ending balance (in shares) at Jun. 30, 2020     226,990,000            
Balances at end of period at Jun. 30, 2020 6,750.7   $ 45.4     654.6   6,102.9 (52.2)
Beginning balances attributable to redeemable non-controlling interests at Mar. 31, 2020 971.0                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (loss) attributable to redeemable non-controlling interests 125.5                
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests (10.3)                
Net subscriptions into T. Rowe Price investment products 26.1                
Net deconsolidations of T. Rowe Price investment products (42.8)                
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2020 1,090.1                
Beginning balance (in shares) at Dec. 31, 2020     227,965,000            
Balances at beginning of period at Dec. 31, 2020 7,707.0   $ 45.6     654.6   7,029.8 (23.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 1,565.1             1,565.1  
Other comprehensive income (loss), net of tax (5.7)               (5.7)
Dividends declared (504.1)             (504.1)  
Special cash dividends declared $ (699.5)             (699.5)  
Shares issued upon option exercises (in shares) 997,788   762,000            
Shares issued upon option exercises $ 29.8   $ 0.2     29.6      
Restricted shares issued, net of shares withheld for taxes (in shares)       4,000          
Net shares issued upon vesting of restricted stock units (in shares)         49,000        
Net shares issued upon vesting of restricted stock units   (4.3)         (4.3)    
Stock-based compensation expense 113.9         113.9      
Restricted stock units issued as dividend equivalents (0.3)         0.2   (0.5)  
Common shares repurchased (in shares)     (1,855,000)            
Common shares repurchased (308.9)   $ (0.4)     (120.3)   (188.2)  
Ending balance (in shares) at Jun. 30, 2021     226,925,000            
Balances at end of period at Jun. 30, 2021 7,893.0   $ 45.4     673.7   7,202.6 (28.7)
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2020 1,561.7                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (loss) attributable to redeemable non-controlling interests 42.4                
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests 8.0                
Net subscriptions into T. Rowe Price investment products 298.9                
Net deconsolidations of T. Rowe Price investment products (1,014.6)                
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2021 880.4                
Beginning balance (in shares) at Mar. 31, 2021     226,948,000            
Balances at beginning of period at Mar. 31, 2021 8,008.2   $ 45.4     654.6   7,338.7 (30.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 815.7             815.7  
Other comprehensive income (loss), net of tax 1.8               1.8
Dividends declared (251.8)             (251.8)  
Special cash dividends declared (699.5)             (699.5)  
Shares issued upon option exercises (in shares)     190,000            
Shares issued upon option exercises 4.3         4.3      
Restricted shares issued, net of shares withheld for taxes (in shares)       4,000          
Net shares issued upon vesting of restricted stock units (in shares)         8,000        
Net shares issued upon vesting of restricted stock units   $ (0.6)         $ (0.6)    
Stock-based compensation expense 56.6         56.6      
Restricted stock units issued as dividend equivalents (0.4)         0.1   (0.5)  
Common shares repurchased (in shares)     (225,000)            
Common shares repurchased (41.3)         (41.3)      
Ending balance (in shares) at Jun. 30, 2021     226,925,000            
Balances at end of period at Jun. 30, 2021 7,893.0   $ 45.4     $ 673.7   $ 7,202.6 $ (28.7)
Beginning balances attributable to redeemable non-controlling interests at Mar. 31, 2021 1,012.9                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (loss) attributable to redeemable non-controlling interests 27.0                
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests (3.8)                
Net subscriptions into T. Rowe Price investment products 111.4                
Net deconsolidations of T. Rowe Price investment products (274.7)                
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2021 $ 880.4                
[1] Accumulated other comprehensive income.